Columbia Labs Inc (NASDAQ:CBRX)
| CAPS Rating |
|
|---|
CBRX
VS S&P 500 (SPY)
CBRX News and Commentary
- NASDAQ Changes Up Biotech Index Members & Weightings – 247wallst
- FDA Issues CRL for Watson's Drug - Analyst Blog – NASDAQ
- Update on Watson's Candidate - Analyst Blog – NASDAQ
- Watson's Drug Fails to Get Support - Analyst Blog – NASDAQ
- 5 of Last Week's Biggest Losers – The Motley Fool
- Columbia Labs Fails to Impress FDA – Blogs @ The Motley Fool
- FDA Staff Critical of Treatment to Reduce Preterm Births – Minyanville
- 1 Reason the Street Should Expect Big Things From Columbia Laboratories – The Motley Fool
- Avoid This Biotech Stock – The Motley Fool
How do you think CBRX will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
73
Outperform
12
Underperform
All-Star Players
12
Outperform
6
Underperform
Wall Street
3
Outperform
0
Underperform
RSS Headlines
Fool UK
